• Learning Objective 1:   Summarize our current understanding of pediatric inflammatory bowel diseases
  • Learning Objective 2:   Describe potential precision medicine biomarkers for pediatric IBD prognosis
  • Learning Objective 3:   Explain the current therapeutic strategies and emerging precision dosing methods


Session date: 
12/16/2021 - 12:00pm to 1:00pm CST
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Ruben Colman, MD